Vitrase Market Report 2026

Vitrase Market Overview

• The Vitrase market growth in the historic period has been driven by expansion of injectable drug therapies, increased use of subcutaneous and intramuscular injections • Market expansion is supported by increasing demand for optimized drug delivery methods, expansion of injectable biologics usage • Growth Driver: Increase In The Diabetic Population Driving Market Growth Due To Rising Prevalence Of Diabetes And Expanding Patient Base • North America was the largest region in 2025.

What Is Covered Under Vitrase Market?

Vitrase is a hyaluronidase-based enzyme used to facilitate the dispersion and absorption of injected drugs and fluids. It is also employed to enhance the effectiveness of subcutaneous and intramuscular injections by breaking down hyaluronic acid in connective tissues. The main types of indications for vitrase are dermatology, oncology, and ophthalmology. Dermatology is the branch of medicine that focuses on the diagnosis, treatment, and prevention of skin, hair, and nail disorders. They are distributed through various distribution channels, such as hospitals, clinics, and online pharmacies and it is used by several end users, including adults and geriatric.

What Is The Vitrase Market Growth Forecast?

The growth in the forecast period can be attributed to increasing demand for optimized drug delivery methods, expansion of injectable biologics usage, growing focus on patient comfort during injections, rising use in specialty medical procedures, increasing innovation in enzyme-assisted delivery systems. Major trends in the forecast period include increasing use of hyaluronidase-enhanced injections, rising demand for improved drug dispersion agents, growing adoption in oncology and ophthalmology procedures, expansion of combination injection therapies, enhanced focus on injection efficiency.

What Are The Drivers Of The Vitrase Market?

The increase in the diabetic population is expected to propel the growth of the vitrase market going forward. The diabetic population refers to individuals diagnosed with diabetes, a chronic condition characterized by elevated blood sugar levels due to insufficient insulin production or ineffective insulin use. The diabetic population is increasing due to factors such as sedentary lifestyles, unhealthy diets, rising obesity rates, aging populations, genetic predisposition, and greater awareness and diagnosis of the condition. Vitrase helps the diabetic population by aiding in the resolution of vitreous hemorrhages and improving the absorption of injected medications, which is especially beneficial for diabetic patients who suffer from diabetic retinopathy and other diabetic eye conditions, thereby enhancing their visual outcomes and overall eye health. For instance, in March 2024, according to the Office for Health Improvement & Disparities, a UK-based government department, between March 2022 and March 2023, the percentage of individuals with type 1 diabetes receiving all eight recommended care processes increased by 22%, and for type 2 diabetes, it increased by 21%, while the percentage achieving target HbA1c levels rose to 37.9%, the highest value ever reported by the National Diabetes Audit (NDA). Therefore, the increasing diabetic population is driving the growth of the vitrase industry. The increasing incidence of eye-related conditions is expected to propel the growth of the vitrase moving forward. Eye-related conditions are disorders that affect the eyes' structure or function, leading to vision impairment or blindness, and can include diseases like cataracts, glaucoma, diabetic retinopathy, and macular degeneration. The prevalence of eye-related conditions is increasing due to factors such as aging populations, the rising incidence of chronic diseases like diabetes, increased exposure to digital screens, and lifestyle factors, leading to higher rates of vision impairment and eye disorders globally. Vitrase helps eye-related conditions by providing an enzyme-based treatment that facilitates the absorption of hyaluronic acid in the vitreous body, which can improve the resolution of macular edema and reduce the impact of eye conditions such as diabetic retinopathy and cataract surgery complications, ultimately aiding in better vision restoration and eye health management. For instance, in September 2024, according to The Guardian, a UK-based news and media organization, myopia is projected to affect more than one in three children and teenagers globally with cases expected to surpass seven hundred forty million by 2050. Therefore, the increasing incidence of eye-related conditions is driving the growth of the vitrase industry. The increasing healthcare expenditure is expected to propel the vitrase market going forward. Healthcare expenditure refers to the total amount of resources allocated to the provision of healthcare services, including funding for hospitals, medical equipment, pharmaceuticals, and personnel. Increasing healthcare expenditure is due to aging populations, rising chronic diseases, advancements in medical technology, and increased patient demand for high-quality care. Rising healthcare expenditure can benefit vitrase by increasing demand for its use in ophthalmic surgeries and improving reimbursement rates. For instance, in October 2025, according to Eurostat, a Luxembourg-based statistical office of the European Union, healthcare expenditure in the European Union was approximately $1,866 billion (€1,720 billion) in 2023 which was 10% of GDP, with Germany recording the highest expenditure at $533 billion (€492 billion). Therefore, increasing healthcare expenditure is driving the growth of the vitrase industry.

Key Players In The Global Vitrase Market

Major companies operating in the vitrase market are Bausch And Lomb Inc.

What Defines the Vitrase Market?

The vitrase market consists of sales of products such as injectable hyaluronidase, collagenases, and recombinant enzymes. This market also encompasses associated costs for distribution, healthcare professional services, and patient support programs. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Vitrase Market Report 2026?

The vitrase market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the vitrase industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.